ObjectiveUp to one-third of women with ovarian cancer in the United States do not receive surgical care from a gynecologic oncologist specialist despite guideline recommendations. We aim to investigate the impact of rurality on receiving surgical care from a specialist, referral to a specialist, and specialist surgery after referral, and the consequences of specialist care.MethodsWe utilized a retrospective cohort created through extension of standard cancer surveillance in three Midwestern states. Multivariable adjusted logistic regression was utilized to assess gynecologic oncologist treatment of women 18\u201389 years old, who were diagnosed with primary, histologically confirmed, malignant ovarian cancer in 2010\u20132012 in Kansas, Mis...
Objectives: Adherence to National Comprehensive Cancer Network (NCCN) guidelines for ovarian cancer ...
The aim of this study was to investigate the association between geographic regions and ovarian canc...
Chemotherapy for ovarian cancer is usually administered by medical oncologists (MOs) or gynecologic ...
A recent ASCO workforce study projects a significant shortage of oncologists in the U.S. by 2020, es...
A recent ASCO workforce study projects a significant shortage of oncologists in the U.S. by 2020, es...
OBJECTIVETo determine the impact of geographic location on advanced-stage ovarian cancer care adhere...
Objective: Given the importance of understanding neighborhood context and geographic access to care ...
BACKGROUND:More than 14,000 women in the United States die of ovarian cancer (OC) every year. Dispar...
Introduction and objective. The aim of the study was evaluation of the urban and rural differences i...
Background:Ovarian cancer is the fifth most common cause of cancer death among women in the United S...
Ovarian cancer is the deadliest gynecologic cancer. Receipt of treatment from a gynecologic oncologi...
Background: The aim of this study was to compare the outcome of treatment for ovarian cancer patient...
Introduction: Although racial/ethnic disparities in ovarian cancer have been documented, factors con...
Background/Aim: To evaluate ovarian cancer surgery in tertiary centers (TC) and regional hospitals (...
Aim: To describe if and to whom gynaecologists refer women with symptoms attributable to endometrial...
Objectives: Adherence to National Comprehensive Cancer Network (NCCN) guidelines for ovarian cancer ...
The aim of this study was to investigate the association between geographic regions and ovarian canc...
Chemotherapy for ovarian cancer is usually administered by medical oncologists (MOs) or gynecologic ...
A recent ASCO workforce study projects a significant shortage of oncologists in the U.S. by 2020, es...
A recent ASCO workforce study projects a significant shortage of oncologists in the U.S. by 2020, es...
OBJECTIVETo determine the impact of geographic location on advanced-stage ovarian cancer care adhere...
Objective: Given the importance of understanding neighborhood context and geographic access to care ...
BACKGROUND:More than 14,000 women in the United States die of ovarian cancer (OC) every year. Dispar...
Introduction and objective. The aim of the study was evaluation of the urban and rural differences i...
Background:Ovarian cancer is the fifth most common cause of cancer death among women in the United S...
Ovarian cancer is the deadliest gynecologic cancer. Receipt of treatment from a gynecologic oncologi...
Background: The aim of this study was to compare the outcome of treatment for ovarian cancer patient...
Introduction: Although racial/ethnic disparities in ovarian cancer have been documented, factors con...
Background/Aim: To evaluate ovarian cancer surgery in tertiary centers (TC) and regional hospitals (...
Aim: To describe if and to whom gynaecologists refer women with symptoms attributable to endometrial...
Objectives: Adherence to National Comprehensive Cancer Network (NCCN) guidelines for ovarian cancer ...
The aim of this study was to investigate the association between geographic regions and ovarian canc...
Chemotherapy for ovarian cancer is usually administered by medical oncologists (MOs) or gynecologic ...